Histopathology revealed B-cell non-Hodgkin lymphoma, confirmed by immunohistochemistry (CD20+, BCL2+, BCL6+, MUM1+, and c-MYC+). This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.